|
|
|
| home > news |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
|
|
PHARM Connect 2019
The Perfect Blend of Science and Business Development
Life science and business are going to meet at PHARM Connect on the
12-13 of March 2019 in Budapest, Hungary to continue the tradition of
providing high calibre, customised professional partnering opportunities
for pharma and biotech professionals from Central & Eastern
European and beyond and deliver the crucial information they need to
excel in their work. The influential annual gathering brings together
over 400 global and regional decision-makers, top scientists, industry
executives and business development leaders for the ninth time to
identify new business opportunities, technologies, state-of-the-art
formulation development strategies and to foster exchange of ideas on
the role of the sector. More>> |
|
|
2019 IPEC Europe Annual Excipients Forum, Malta, 31 January
Join NSF at this dynamic conference in Malta on the 31st January 2019, recognised to be one of the key events for pharmaceutical excipients in Europe.
More>> |
|
|
RSSL introduces same-day mycoplasma testing service in UK
Reading Scientific Services Ltd (RSSL), a leading provider of scientific
and technical solutions to the global biopharmaceutical,
pharmaceutical, and biopharmaceutical sectors, has introduced the United
Kingdom’s first same-day mycoplasma testing service for manufacturers
of biologic medicines.
More>> |
|
|
+44 (0)118 918 4024
|
|
www.rssl.com
|
|
University of Reading, Whiteknights Rd, Reading, West Berkshire RG6 6LA
|
| |
|
Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific
Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide
high-quality cGMP quaternary ammonium compounds in twelve countries
across Asia Pacific More>> |
|
|
|
 |
|
|
 |
News and Press Releases |
 |
2019 IPEC Europe Annual Excipients Forum, Malta, 31 January
Join NSF at this dynamic conference in Malta on the 31st January 2019, recognised to be one of the key events for pharmaceutical excipients in Europe.
More info >> |
|
 |
White Papers |
 |
|
Future-proofing serialization solutions: the importance of strong level 3 capabilities
Adents
The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >> |
|
 |
Industry Events |
 |
BioTrinity 2019
30 April - 1 May 2019, etc.venues 155 Bishopsgate, London EC2M 3YD
BioTrinity 2019 is taking
place from the 30th April – 1stMay at etc.venues 155 Bishopsgatein London. Now in its 13th year, BioTrinity remains the leading Life Sciences Biopartnering
and Investment conference in Europe, and generates unrivalled opportunities for
life science companies, academics, investors, and major pharmaceutical players
to come together to do deals and establish collaborations.
More info >> |
|
|
